Cantor Fitzgerald reiterated its Overweight rating and $122 price target on Rocket Lab on October 19, 2026. The reaffirmation came amid significant market turmoil for the company.
Rocket Lab shares fell more than 25% in the past week and closed at $50.84. The stock has lost 38% of its value since October 7.
Two recent developments contributed to the decline. Rocket Lab said manufacturing issues would delay the inaugural launch of its larger Neutron rocket until 2027.
The company’s proposed $8 billion acquisition of Iridium also faces a regulatory challenge. Ligado Networks urged the FCC to scrutinize the deal over competitive concerns.